• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses. The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor

tetano

Editor, Senior Moderator
Viruses. 2020 Apr 30;12(5). pii: E497. doi: 10.3390/v12050497.
The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor.


Brielle ES[SUP]1,[/SUP][SUP]2[/SUP], Schneidman-Duhovny D[SUP]1,[/SUP][SUP]3[/SUP], Linial M[SUP]1[/SUP].

Author information




Abstract

The COVID-19 disease has plagued over 200 countries with over three million cases and has resulted in over 200,000 deaths within 3 months. To gain insight into the high infection rate of the SARS-CoV-2 virus, we compare the interaction between the human ACE2 receptor and the SARS-CoV-2 spike protein with that of other pathogenic coronaviruses using molecular dynamics simulations. SARS-CoV, SARS-CoV-2, and HCoV-NL63 recognize ACE2 as the natural receptor but present a distinct binding interface to ACE2 and a different network of residue-residue contacts. SARS-CoV and SARS-CoV-2 have comparable binding affinities achieved by balancing energetics and dynamics. The SARS-CoV-2-ACE2 complex contains a higher number of contacts, a larger interface area, and decreased interface residue fluctuations relative to the SARS-CoV-ACE2 complex. These findings expose an exceptional evolutionary exploration exerted by coronaviruses toward host recognition. We postulate that the versatility of cell receptor binding strategies has immediate implications for therapeutic strategies.



KEYWORDS:

ACE2; SARS-CoV-2; coronavirus evolution; molecular dynamics; protein–protein complex; virus–host interactions


PMID:32365751DOI:10.3390/v12050497
 
Back
Top